News Agency
Men's Weekly

CARsgen's CT011 achieves IND clearance from the NMPA for the GPC3-positive stage Ⅲa hepatocellular carcinoma at high risk of recurrence after surgical resection

  • Written by PR Newswire
CARsgen's CT011 achieves IND clearance from the NMPA for the GPC3-positive stage Ⅲa hepatocellular carcinoma at high risk of recurrence after surgical resection

SHANGHAI, Jan. 15, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announces that CT011, an autologous CAR T-cell product candidate against Glypican-3 (GPC3), has achieved Investigational New Drug...

Read more: CARsgen's CT011 achieves IND clearance from the NMPA for the GPC3-positive stage Ⅲa...

Hard Chrome Plating: Enhancing Durability And Performance In Industrial Components

In industries where equipment is exposed to constant friction, pressure, and harsh operating conditions, surface protection becomes critical to performance and longevity. Hard chrome plating is a specialised surface treatment process widely used to improve wear resistance, reduce friction, and extend... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion